Cancer - Press review (December 10, 2011) – Revue de presse (10 décembre 2011)

[SciMedWeb]

Cancer – Press Review – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review (December 10, 2011) – Revue de presse (10 décembre 2011)


Two Drugs Offer New Hope for Breast Cancer Patients
It's not often that researchers get to report good news for cancer
patients, but this week at the San Antonio Breast Cancer Symposium,
researchers announced encouraging results from studies of two cancer
medications (pertuzumab and everolimus) that appeared to keep women's
disease from advancing.
By Alice Park. TIME
http://healthland.time.com/2011/12/08/two-drugs-offer-new-hope-for-breast-cancer-patients/

Stanford, UCSF to test ultrasound for cancer pain
Scientists at Stanford and UCSF are recruiting patients for two
clinical trials to test the use of ultrasound waves, as an alternative
to traditional radiation therapy, to ease pain in people whose cancer
has spread to their bones.
By Erin Allday. In San Francisco Chronicle
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2011/12/04/BATE1M79J2.DTL

Ex-chief of Japan nuclear plant has cancer
The former chief of Japan's crippled nuclear plant, who left the job
last week, has cancer of the esophagus, TEPCO said Friday, adding it
was unlikely to be linked to radiation exposure.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5iX10KfPyCTZukARxlGJOegZLp8kg?docId=CNG.33ba93cd99323b241fb70a8bcd7637cf.5f1



40% Of Cancers Attributed To Preventable Factors
More than 100,000 cancers - nearly 4 in 10 of all those diagnosed in
Britain each year - could be prevented if people made different
choices, according to a new study by Cancer Research UK.
In Huffington Post
http://www.huffingtonpost.com/2011/12/07/40-of-cancers-attributed-_n_1135015.html

Active Surveillance May Benefit Men With Low-Risk Prostate Cancer
But report says more needs to be known about the long-term outcome of
this approach.
By Steven Reinberg. In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/12/07/active-surveillance-may-benefit-men-with-low-risk-prostate-cancer

Should Nuns Take the Pill for Health Reasons?‎
The world’s 94,790 nuns pay a price for their chastity: an increased
risk of breast, ovarian and uterine cancers.
By Katie Moisse. ABC News (blog)
http://abcnews.go.com/blogs/health/2011/12/08/should-nuns-take-the-pill-for-health-reasons/

EUROECHO: Cancer Drug Has Early Cardiac Effects
Breast cancer patients often develop early signs of cardiotoxicity
within months of starting treatment with trastuzumab (Herceptin),
according to a small study with implications for heart failure
prevention.
By Crystal Phend. MedPage Today
http://www.medpagetoday.com/MeetingCoverage/EUROECHO/30100?pfc=101&spc=230

FDA panel backs Pfizer's drug for kidney cancer (axitinib - Inlyta)
Pfizer Inc won unanimous expert backing for its Inlyta experimental
drug for patients with advanced kidney cancer.
By Anna Yukhananov. In Reuters
http://www.reuters.com/article/2011/12/07/us-fda-pfizer-inlyta-idUSTRE7B625720111207

Cancer : pas de périostine, plus de métastase !
Des scientifiques suisses affirment avoir trouvé un élément clé
toujours impliqué dans l'établissement des métastases : la périostine.
Après l'inhibition de cette protéine de la matrice extracellulaire
chez des souris, les cellules cancéreuses n’ont jamais pu coloniser un
nouvel organe. Une nouvelle piste à explorer au plus vite ! Par Janlou
Chaput. Dans Futura Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-pas-de-periostine-plus-de-metastase_35166/

Cancer: Génopharm bientôt suspendu
Le laboratoire français Genopharm, accusé d'avoir commercialisé des
lots périmés d'un anticancéreux, le Thiotepa, va recevoir "sous peu"
la lettre qui suspend son autorisation d'exercer en France, a indiqué
aujourd'hui l'agence du médicament (Afssaps).
Dans Le Figaro.
http://www.lefigaro.fr/flash-actu/2011/12/08/97001-20111208FILWWW00768-cancer-genopharm-bientot-suspendu.php

La maternité protège du cancer
À défaut d'enfants, des chercheurs australiens proposent… la pilule!
Par Damien Mascret. Dans Le Figaro
http://www.lefigaro.fr/sciences/2011/12/07/01008-20111207ARTFIG00831-la-maternite-protege-du-cancer.php

Cancer du sein : la survie des femmes accrue par une combinaison de
deux molécules‎
Selon une récente étude américaine, la prise combinée de deux
molécules particulières augmenterait la survie des femmes atteintes du
cancer du sein le plus fréquent.
Dans Maxi-Sciences
http://www.maxisciences.com/cancer-du-sein/cancer-du-sein-la-survie-des-femmes-accrue-par-une-combinaison-de-deux-molecules_art19416.html

Santé: Cas de cancer du poumon en Algérie‎
Traitement cancer du poumon - 3 500 cas de cancer du poumon
diagnostiqués chaque année. Le cancer du poumon est la cause la plus
fréquente des décès dus au cancer chez les hommes et les femmes à
travers le monde. L'Algérie n'échappe pas à ce fléau ravageur.
Par Amel Bouakba. Dans Afrique en Ligne
http://www.afriquejet.com/traitement-cancer-poumon-2011120729093.html








Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – InTextoResearch – Baelen (12/2011)